Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, this is all good, Mr. Nurse is getting this company going, UP
I agree Bob, more contracts, imo Mr. Nurse wants this company back to dollar land.
Florida investors, we do not need this:
http://www.weatherunderground.com/tropical/tracking/at200524_model.html
Anytime JT, I had E*Trade on the phone last night and I am working on it.
CALL YOUR BROKER: Interesting:
Posted by: angelhillcorp
In reply to: BuzzOnDaBeach who wrote msg# 112490 Date:10/13/2005 10:21:12 PM
Post #of 112491
ALERT >>>>>>>
I talked with Ameritrade Shorts dept and he said that any stock that becomes part of their inventory can be shorted and it does not matter if it is already up for sale by the owner .. Sound like if a company has 10M O/S its actually 20M O/S because they can all be borrowed to shorted ....
Even thou money value is only calculated to the owned share certificate thru the Depository Trust ..
Some sick barbaric forefathers of the stock market really rigged some senseless rules to hell ......
Explains the great stock crash .....
Explains the crash in the market the last 5 years and the debt deficient greatly increasing as the whole market becomes electronically traded ......
Double Jeopardy with the Depository Trust ..
Ameritrade says the only way you can protect your account from shorting is if you call them up and designate to them that your entire account can not be borrowed on to be shorted ...
I requested that they inform all of their clients on this no short option when they open an account with them .. He said it is not even availiable on their website and very few know about it ... I requested that they make this no short option availiabe on their website ....
I also requested that every time someone buys a stock they have the option to designate that this stock owned can not be borrowed to be shorted by clicking on the request or verbal recognition ....
I explained to him that I am currently working the SEC To make this option of No Short Designation a regulation of SEC National Enforcement Policy with every Brokerage firm and Market Maker dealing with the United States Trades Commission ..
The party of a stock purchase can immediatly designate that this stock "Owned Cannot Be Borrowed To Be Shorted" ....
I talked with NITE MM compliance dept. and they said they can short any stock that is availiable in their clearing house.
On another note it has come to my attention in reference to Fraud Stock & Naked Shorting from foreign firms that there is more counterfeit USA dollars abroad and in South America in circulation than legit dollars .. put that to perspective in the stock market with open boundary free trading .....
CALL YOUR BROKER: Interesting:
Posted by: angelhillcorp
In reply to: BuzzOnDaBeach who wrote msg# 112490 Date:10/13/2005 10:21:12 PM
Post #of 112491
ALERT >>>>>>>
I talked with Ameritrade Shorts dept and he said that any stock that becomes part of their inventory can be shorted and it does not matter if it is already up for sale by the owner .. Sound like if a company has 10M O/S its actually 20M O/S because they can all be borrowed to shorted ....
Even thou money value is only calculated to the owned share certificate thru the Depository Trust ..
Some sick barbaric forefathers of the stock market really rigged some senseless rules to hell ......
Explains the great stock crash .....
Explains the crash in the market the last 5 years and the debt deficient greatly increasing as the whole market becomes electronically traded ......
Double Jeopardy with the Depository Trust ..
Ameritrade says the only way you can protect your account from shorting is if you call them up and designate to them that your entire account can not be borrowed on to be shorted ...
I requested that they inform all of their clients on this no short option when they open an account with them .. He said it is not even availiable on their website and very few know about it ... I requested that they make this no short option availiabe on their website ....
I also requested that every time someone buys a stock they have the option to designate that this stock owned can not be borrowed to be shorted by clicking on the request or verbal recognition ....
I explained to him that I am currently working the SEC To make this option of No Short Designation a regulation of SEC National Enforcement Policy with every Brokerage firm and Market Maker dealing with the United States Trades Commission ..
The party of a stock purchase can immediatly designate that this stock "Owned Cannot Be Borrowed To Be Shorted" ....
I talked with NITE MM compliance dept. and they said they can short any stock that is availiable in their clearing house.
On another note it has come to my attention in reference to Fraud Stock & Naked Shorting from foreign firms that there is more counterfeit USA dollars abroad and in South America in circulation than legit dollars .. put that to perspective in the stock market with open boundary free trading .....
Hey Buzz, remember this:
SPWP up 185% today.
Stiil here, working on it, thanks zdeep1.
SiteWorks Building Announces USD10,000,000 GMP Contract for Approx. 1,100 Affordable Units
Friday October 7, 6:00 pm ET
MIAMI, FL--(MARKET WIRE)--Oct 7, 2005 -- Management of SiteWorks, Inc. (OTC BB:SWKJ.OB - News), a construction and real estate development company, announced today that the company has signed a guaranteed maximum Price Contract with Knightsbridge Law Co. Ltd, a Thai firm, for the construction of affordable housing in Lopburi Province, Thailand.
ADVERTISEMENT
CEO C. Michael Nurse stated, "These houses are built pursuant to a government initiative for low cost units. This contract which has a GMP (guaranteed maximum price) of 10,000,000 USD is the first of several projects we expect to secure through the help of our local business development agent Prestige Asia. We expect work to begin within the next several weeks on this particular contract. We are in negotiations on a number of other projects and we expect the status of those discussions will be announced in the near future."
SiteWorks, Inc. is a Florida company engaged in the business of total site and built environment solutions. The company's core business is the construction of semi custom housing developments condo conversions, and middle-income multifamily buildings. SiteWorks, Inc. also performs construction management and general construction services. Other services provided include the marketing and distribution of innovative construction related and other technology products.
This press release contains "forward-looking" statements as that term is defined by Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). All statements that are included in this press release other than statements of historical fact are "forward-looking" statements. Although SiteWorks believes that the expectations reflecting in these forward-looking statements are reasonable, it can give no assurance that such expectations will materialize. Important factors could cause actual results to differ materially from the expectations as disclosed herein, including without limitation, in conjunction with these forward-looking statements contained in this press release.
SiteWorks Building Announces USD10,000,000 GMP Contract for Approx. 1,100 Affordable Units
Friday October 7, 6:00 pm ET
MIAMI, FL--(MARKET WIRE)--Oct 7, 2005 -- Management of SiteWorks, Inc. (OTC BB:SWKJ.OB - News), a construction and real estate development company, announced today that the company has signed a guaranteed maximum Price Contract with Knightsbridge Law Co. Ltd, a Thai firm, for the construction of affordable housing in Lopburi Province, Thailand.
ADVERTISEMENT
CEO C. Michael Nurse stated, "These houses are built pursuant to a government initiative for low cost units. This contract which has a GMP (guaranteed maximum price) of 10,000,000 USD is the first of several projects we expect to secure through the help of our local business development agent Prestige Asia. We expect work to begin within the next several weeks on this particular contract. We are in negotiations on a number of other projects and we expect the status of those discussions will be announced in the near future."
SiteWorks, Inc. is a Florida company engaged in the business of total site and built environment solutions. The company's core business is the construction of semi custom housing developments condo conversions, and middle-income multifamily buildings. SiteWorks, Inc. also performs construction management and general construction services. Other services provided include the marketing and distribution of innovative construction related and other technology products.
This press release contains "forward-looking" statements as that term is defined by Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). All statements that are included in this press release other than statements of historical fact are "forward-looking" statements. Although SiteWorks believes that the expectations reflecting in these forward-looking statements are reasonable, it can give no assurance that such expectations will materialize. Important factors could cause actual results to differ materially from the expectations as disclosed herein, including without limitation, in conjunction with these forward-looking statements contained in this press release.
The building will continue:
Hundreds feared dead in South Asia quake
Last Updated Sat, 08 Oct 2005 06:39:33 EDT
CBC News
One of my best picks yet, good to hear from you taki
SWKJ ready to explode.
SWKJ ready to explode.
SWKJ ready to explode.
Bid and ask at .05
Could one of you experts look at this about SWKJ and tell me what you think:
http://charts3.barchart.com/procal.asp?sym=SWKJ
Before the bell again, SWEEEEEEEEET
WATCH SWKJ
guys look at Germany...its exploding (+118%)
Volumen Taxe
- 0,041 + 118%
Kauf Orders
Stücke Limit
40.000 0,041
50.000 0,04
40.000 0,033
160.000 0,031
70.000 0,03
Weitere: 2
Best Ask
Taxe Volumen
0,05 -
Verkauf Orders
Limit Stücke
0,049 65.900
0,05 162.850
0,052 25.000
0,055 25.000
0,07 100.000
Germany is going crazy fpr Sitewoks...
The explosion has come!!!
go to www.consors.de and enter Siteworks
you can also get rt quotes and ordebook for free at www.berlinerboerse.de
you have to apply but it is for free
NEWS
SiteWorks Building & Development Co., Announces It Has Submitted Proposals to Develop and Build Low Cost Alternative for Affordable Housing in Thailand
September 09, 2005 13:00:02 (ET)
MIAMI, Sep 09, 2005 (BUSINESS WIRE) -- -SiteWorks, Inc. (SWKJ, Trade) has announced the company has submitted proposals to build low cost housing near the Thai International Airport.
The construction work will be done by a local Thai company using a pre-cast concrete methodology used extensively in the West, but which has not yet been fully exploited in the Far East.
Projects which are being proposed include housing for the National Housing Authority and other governmental agencies.
SiteWorks CEO, Michael Nurse stated "The technology we propose has been used extensively here in the West and can be used anywhere there is a need for durable low cost housing. If our proposals are accepted, we are planning to finalize the transfer of technology by early November and have the projects start up in early 2006.
SiteWorks, Inc. is a Florida company engaged in the business of total site and built environment solutions. The company's core business is the construction of semi custom housing developments and middle-income multifamily buildings. Site-Works, Inc also performs construction management and general construction services. Other services provided include the marketing and distribution of innovative construction related and other technology products.
Statements contained in this press release that are not based upon current or historical fact are forward-looking in nature. Such forward-looking statements reflect the current views of management with respect to future events and are subject to certain risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated or expected, or described pursuant to similar expressions.
SOURCE: SiteWorks, Inc.
SiteWorks, Inc.
L. Konrath, 305-573-9339
cnurse@mysiteworks.net
www.siteworks-inc.com
Copyright Business Wire 2005
Anybody have a opinion?
'China has f*cked us' - Bill Gates
http://www.theregister.co.uk/2005/09/07/microsoft_google/
News!
13:05 ET MIAMI--(Business Wire)--Aug 26, 2005--
Site Works Building & Development Co. (OTCBB:SWKJ.U) CEO
Michael Nurse has announced the company has signed a formal Loan
commitment agreement with Allied Mortgage of Hollywood, Florida on
August 24, 2005.
The loan is for $1,260,000 and funds will be used to complete a
build out of commercial space at the Chiefland project. The terms of
the commitment indicate that actual funding will occur within thirty
days of the execution date. Mr. Nurse noted that "even though the
funding process has been delayed due to the very busy appraiser's
schedule, we still expect to see revenues from the sale and or lease
of the space this fiscal year."
Site Works Inc. is a real estate and construction company engaged
in the business of total site and built environment solutions. The
company's core business is the construction of semi custom housing
developments and middle-income multifamily buildings. Site Works Inc.
also performs construction management and general construction
services. Other services provided include the marketing and
distribution of innovative construction-related and other technology
products.
Statements contained in this press release that are not based upon
current or historical fact are forward-looking in nature. Such
forward-looking statements reflect the current views of management
with respect to future events and are subject to certain risks,
uncertainties and assumptions. Should one or more of these risks or
uncertainties materialize or should underlying assumptions prove
incorrect, actual results may vary materially from those described
herein as anticipated, believed, estimated or expected, or described
pursuant to similar expressions.
CONTACT: for Site Works
Lisa Konrath, 305-573-9339
www.mysiteworks.net
or
Kevin Gray, 212-423-1040
Siteworks@gfsinvestmentsonline.com
KEYWORD: 'UNITED STATES' 'NORTH AMERICA' 'FLORIDA'
INDUSTRYKEYWORD: 'PROFESSIONAL SERVICES' 'FINANCE' 'COMMUNICATIONS'
'PUBLIC RELATIONS/INVESTOR RELATIONS' 'CONSTRUCTION & PROPERTY'
'COMMERCIAL BUILDING & REAL ESTATE'
'RESIDENTIAL BUILDING & REAL ESTATE'
SOURCE: Site Works
taki, keep the faith brother, your dad is in a better place.
This is by far a better board the the stories going on on Raging Bull. To many post there, just wishful thinking.
What is this?
HTTD is no longer a “one-drug company” that is reliant solely on the promotion of Tubercin®. In addition to the companies proprietary formulation and various compounds, referenced in the provisional application, HTTD also acquired and holds the worldwide (except Korea) marketing rights and license to manufacture, use, market, distribute and otherwise to commercialize Tubercin®, which includes Tubercin®’s issued patents in the following countries:
Japanese patent: issued 6/12/98
United States patent: issued 8/14/01
European patent: issued 8/13/03
Canada patent: issued 5/11/04
???????????????/
Two things. Shinn capital has the Rights to Tubercin, just like they always did. Shinn Capital sublicensed those rights to HTDS and T-19. That's the Share Exchange Agreement (SEA) that everyone is talking about. Shinn argued that it never closed and so was not binding. HTDS was arguing that it DID close. We won. It DID close.
What does this mean? It means that things go back to the way they were before the Shinn tried to hump us. Shinn Capital owns the rights to Tubercin and HTDS has the sublicensed rights to Tubercin from Shinn Capital.
HTDS gets to market tubercin
DECISION RENDERED: Hard to Treat Diseases, Inc. v. Shinn et al., 04-800010. The court has entered a memorandum opinion with findings of fact and conclusions of law holding that (1) the parties' share exchange agreement did close,
On May 2, 2003 International Foam Solutions, Inc.(“IFS”) completed a share exchange agreement with Shinn, and Oklahoma companies Hard to Treat Diseases, Inc.(“HTTD”) and T-19, Inc.(“T-19”). Shinn was to receive stock in IFS in return for 100 % of the stock in HTTD and T-19.
As a condition of the share exchange agreement, the name of the publicly traded entity owning all three companies was changed from International Foam Solutions, Inc. to Hard to Treat Diseases, Incorporated
WE WIN
;) you bunch of sillies
Based upon the foregoing Findings of Fact and Conclusions of Law, Judgment shall be
entered by the Clerk of Courts in favor of Plaintiff Hard to Treat Diseases, Inc . f/k/a International
Foam Solutions, Inc ., with costs .
When this PR comes out, IT WILL BE RIGHT, IT WILL BE CLEAR AS MR. KING ALWAYS PUTS THEM.
IT WILL BE HUGE.
Court Findings:
Findings In PDF
Shinn findings http://webpages.charter.net/cybermed/shinnfof.pdf
684KB
htds findings
http://webpages.charter.net/cybermed/htdsfof.pdf
1MB
I feel Mr. King has the better contracts, the judge will decide.
Hard to Treat Diseases Incorporated --
HTTD – Announces: Letter to the Shareholders
Delray Beach, Fla., July 28, 2004 – Hard to Treat Diseases Incorporated (HTTD) (Pink Sheets:HTDS)
A Letter from Hard to Treat Diseases, Incorporated
This letter is in response to the concerns of certain shareholders and an opportunity to offer an overview of the past, present and future of our Company. Topics of concern and areas of importance are addressed below.
LITIGATION UPDATE:
As many of you are aware, this company has filed suit against Ronald Shinn and Gerry Knight, alleging various breaches of fiduciary duties they owed Hard to Treat Diseases, Inc. during their tenure as officers and directors of this Company and tortuous interference with Hard to Treat Diseases, Inc.’s business and contractual relationships. This case is pending in Federal Court, styled, Hard to Treat Diseases, Inc. f/k/a International Foam Solutions, Inc. v. Shinn, et al., Case No. 04-80010-CIV-Hurley. Shinn and Knight challenged the jurisdiction of that court and filed a Motion to Dismiss for Lack of Personnel Jurisdiction, or Alternatively, a Motion to Transfer the Case (to Oklahoma). On July 19, 2004, the Federal District Court entered an order Denying Shinn and Knight’s Motion to Dismiss or, alternatively, Motion to Transfer. Trial in this case is currently set for January, 2005.
Tubercin® TESTING:
Prior testing conducted at the University of Oklahoma Health Science Center concluded favorable results regarding Tubercin®’s toxicity trials and preliminary efficacy study.
The Denver Veteran’s Affairs Medical Center and the University of Colorado Health Sciences Center’s confidence in uses of Tubercin® are self-evident; otherwise they would not have wasted their valuable time and resources. The inventor of Tubercin®, Dr. Chung, has over 18 years of promising results for Tubercin® in South Korea. We have testing results and testimonials from patients who had terminal cancer, were treated with Tubercin ®and are still alive today. These treatments were conducted outside the US, so that the FDA does not recognize the results.
Our goal with Tubercin® is basic and straightforward:
1) aggressively advance the testing of Tubercin® under FDA guidelines
2) make strategic decisions
3) to be involved in negotiations with major drug firms within two years for the rights to Tubercin®
4) get Tubercin® to the patients who need it as fast as possible
Shareholders will be made aware of test results as soon as we receive them. There is nothing we can do to speed up the process!
T-19®:
The prior CEO of Hard to Treat Diseases, Inc.(“HTTD”), Ronald Shinn, announced in a press release of June 6, 2003 that “Due to the homeopathic nature of T-19®, the nasal spray application method of application does not require FDA approval in the USA and can be put on the holistic market immediately at relatively low cost.” in a subsequent press release on June 16, 2003, he stated that “T-19® Holistic Nasal Spray, to be available to the general public through holistic retailers, providers and practitioners worldwide, uses Tubercin®, an immune system builder, as its main ingredient.”
Current management announced in the press release of February 9, 2004 that “It is expected that a decision will be made sometime this month regarding the most expeditious manner to safely make available T-19® to the people who need it…The company’s consultants are also meeting with an FDA approved P-3 manufacturer regarding T-19®. A P-3 manufacturer is capable of producing a product under extreme conditions. Tubercin® and the related T-19® are produced from live Tuberculosis cells under extremely stringent conditions. Depending on the approval process required by the testing facility and the opinion of the Company’s Scientific Advisory Panel, the delivery system for the T-19® will either be a nasal spray or an inhaler. The holistic market for T-19® as an immunostimulant has phenomenal potential. We intend to get T-19® on the market as fast as possible.”
Current management cannot discover any factual basis supporting the former CEO, Shinn’s, claims that T-19® does not require FDA approval in the United States. No testing has been conducted in the USA at the point in time those statements were made.
The FDA bases their approval on testing conducted in the U.S. at FDA approved facilities; the FDA does not base its decisions on research and treatments done in Korea;. T-19® may well require FDA approval since it is produced from live Tuberculosis. For that reason, if testing proves that T-19® does not require FDA approval, we are prepared to immediately manufacture, market and distribute T-19®. We have a P-3 manufacturer ready to start production.
At this point we do not have clearance to manufacture T-19® without FDA approval. If we receive clearance this would be an immediate source of revenue for HTTD from the holistic market and the shareholders would be notified immediately. We do not want to jeopardize the regulatory approval of Tubercin® or proceed in any manner that could lead to unanticipated delays or expenses.
SALE OF RECYCLING ASSETS:
On May 21, 2004 it was announced that HTTD sold the assets of its recycling division for a secured promissory note of $250,000 and 20% ownership of the purchasing company. This sale was the best financial option for HTTD regarding the recycling assets. HTTD did not have the updated technology, the capital or resources in order to move the recycling division forward; we could not consummate a transaction with China or increase the domestic marketing of the division.
The assets were purchased by International Foam Solutions, Inc.,(“IFS”) a Nevada corporation controlled by Harvey Katz. Mr. Katz was the President of HTTD prior to the acquisition of Hard to Treat Diseases, Inc. and T-19, Inc. Certain shareholders have questioned the transaction as not being an arms length transaction or possibly an inside deal. The facts contradict any such concern.
First, the only other offer to purchase the recycling assets and technology was from Commonwealth Industries, Inc. for $190,000 in August 2003. Commonwealth decided not to purchase the assets, because the cost and time necessary to gain momentum in the polystyrene recycling industry was prohibitive.
Second, another alternative was to raise capital to acquire the technology, pay consultants, and continue or expand operations. This was discarded due to the cost of raising such capital for the recycling division when HTTD has committed itself to focusing on growing as a biotechnology company.
Third, the option HTTD pursued, is in management’s opinion, the best result for HTTD and its shareholders. The company will receive a $250,000 capital infusion over the next year. In addition, HTTD’s ownership of 20% of the recycling company will allow us to participate in the success of that company. We have every reasonable expectation that Mr. Katz’s fourteen years experience in the polystyrene industry is best put to use in growing International Foam Solutions instead of paying him as a consultant and trying to raise capital to expand a recycling division. IFS is currently in the process of attempting to finalize letters of intent with the Peoples Republic of China, with a private entity regarding dock recycling at the Lakes of the Ozarks in Missouri, and with the tobacco industry. IFS is also in the process of raising capital in order to expand operations and accelerate the payment due to HTTD. Thus, the expense of expanding IFS is borne by that company and not HTTD. As soon as a contract is signed that will generate revenue to HTTD, the shareholders will be notified immediately. Harvey Katz remains a consultant to HTTD in relation to the advancement of Tubercin®.
I have been and will continue to act as a watchdog over the operations of IFS to act in the best possible interests of HTTD and its ownership stake in IFS.
LITIGATION WITH SHINN—BACKGROUND:
HTTD is currently involved in litigation with its former CEO Ronald Shinn and former Secretary Gerry Knight, due to their transactions of questionable legality that were contrary to the interests of HTTD’s shareholders.
On May 2, 2003 International Foam Solutions, Inc.(“IFS”) completed a share exchange agreement with Shinn, and Oklahoma companies Hard to Treat Diseases, Inc.(“HTTD”) and T-19, Inc.(“T-19”). Shinn was to receive stock in IFS in return for 100 % of the stock in HTTD and T-19.
Pursuant to the share exchange agreement, Harvey Katz resigns as President and CEO and Shinn becomes President and CEO.
As a condition of the share exchange agreement, the name of the publicly traded entity owning all three companies was changed from International Foam Solutions, Inc. to Hard to Treat Diseases, Incorporated.
Pursuant to the share exchange agreement, on May 9, 2003 Shinn and his wife are issued 350 million restricted common stock shares of HTTD.
On June 30, 2003 Shinn issues himself an additional 175 million restricted common stock shares of HTTD.
On August 18, 2003 Shinn issues himself an additional 5 million restricted common stock shares of HTTD.
During his tenure as CEO of HTTD, Shinn stated to me and others that he was very interested in selling HTTD in order to convert his equity stake to cash.
We were unaware that the Tubercin® toxicity testing was completed on October 8, 2003 and that the results were favorable, but we later discovered that Shinn was aware of the results on October 8, 2003. On October 13, 2003, Shinn, his wife, and Knight resigned.
On October 15, 2003 Shinn, acting through his lawyer, sent a letter to HTTD through one of HTTD’s shareholders stating his intention to rescind and terminate the Share Exchange Agreement dated May 2, 2003. He also tendered the original stock certificates for the 530 million restricted shares of common stock. In essence, Shinn wanted to unravel the “merger” of a publicly traded company.
Hence, we are involved in litigation with Shinn. I’m confident the outcome will be favorable for HTTD or I would not be sitting where I am working for the shareholders.
SHINN’S 530 MILLION SHARES:
The original stock certificates for Shinn’s 530 million shares are in escrow, frozen and non-voting. The shares have not been cancelled yet, they are part of HTTD’s issued and outstanding stock! The certificates are not cancelled because they are part and parcel of the terms of the share exchange agreement, which is binding and provided the company with 100% share ownership in HTTD and T-19.
REPORTING ENTITY:
HTTD is currently on the “pink sheets” as a non-reporting entity. Our auditors cannot finalize HTTD’s audit for the year ended December 31, 2003, because Shinn has withheld the necessary documents regarding the companies we acquired. Of course this is part of our litigation with him.
Our goal is to become a reporting entity. This will add credibility to the company and give shareholders and potential investors a better understanding of HTTD.
WEBSITE:
On March 3, 2004 HTTD announced its new website that was professionally designed with “Flash” technology. Not much has been done with the website since then.
We have the foundation of a user friendly, informative and professional website. Commencing August 2, 2004 time and resources will be allocated for website development to make it a useful tool for shareholders and investors.
“CHAT ROOM” GOSSIP:
It seems there have been some far-fetched conspiracy theories circulating on some of the chat room message boards regarding HTTD. Certain shareholders have been kind enough to forward some of the theories to me. I’d like to state the following facts:
1) There is currently no investigation by the SEC or any other regulatory authority against HTTD, of which we are aware. If we are notified of any inquiry we will offer our full cooperation and assistance.
2) HTTD is not contemplating or in the process of filing bankruptcy.
3) HTTD restricted shares under Rule 144, with a holding period of at least one year, have been issued to me. I have not sold any HTTD shares to date nor do I intend to.
4) HTTD is not involved in the manipulation of its stock price nor does it exercise any control over the market. As discussed in our press release on December 5, 2003, third party individuals or entities have released information about the company. The company urges all shareholders and potential investors to review the company’s press releases and web site rather than relying on non-company disseminated information.
CONCLUSION:
HTTD is on track with the plan for the testing and advancement of Tubercin® and to be involved with a major pharmaceutical company within two years. HTTD will do nothing to jeopardize Tubercin® or the company. We are and will remain in complete compliance with FDA regulations, SEC compliance and all regulatory agencies. HTTD will keep its shareholders informed of all updates, vigorously protect the shareholder’s investments in the company and work aggressively in order for the shareholders to expeditiously begin to reap the benefits of our drug testing.
Feel free to call me if you have any questions or concerns regarding the company or my performance.
Sincerely,
Colm J. King
President and CEO
Hard to Treat Diseases, Incorporated
(561) 272-6900
This letter can also be viewed on our webste:www.htdsotc.com
I think we need more info before we send in any share cert,
HTDS climbing
ok, CYBL boooooooooooom
CYBL Weeeeeeeeeeeeeeeee